Background: The clinical outcome for the individual prostate cancer patient is often difficult to predict, due to lack of reliable independent prognostic biomarkers. We tested DNA ploidy as a prognostic factor for clinical outcome in 186 patients treated with radical prostatectomy
Prostate cancer represents a major global challenge, with 1.1 million new cases in 2012. According t...
We report our experience with 85 prostatic cancer patients aged 51-79 years, who underwent radical r...
SummaryBackgroundOptimum management of clinically localised prostate cancer presents unique challeng...
Background. DNA ploidy analysis has been investi-gated as a prognostic indicator in prostate cancer....
Prostate-specific antigen (PSA) and DNA ploidy as measured by flow cytometry were compared with conv...
BACKGROUND. The optimal approach to diagnosis and treatment of localized prostate cancer remains con...
Background: The ability to accurately predict tumor behavior and patient survival is a problem in ma...
CONTEXT: Given the highly variable behavior and clinical course of prostate cancer (PCa) and the mul...
ContextGiven the highly variable behavior and clinical course of prostate cancer (PCa) and the multi...
Background. DNA ploidy determination of carcino-mas in radical prostatectomy specimens has shown sig...
We have used image cell analysis to analyse nuclear DNA content on fine needle aspiration biopsies f...
Prostate cancer is one of the most frequent cancers in men and is a common cause of cancer-related d...
textabstractNo objective parameters have been found so far that can predict the biological...
Aneuploidy, defined as chromosome gains and losses, is a hallmark of cancer. However, compared with ...
Background. A characteristic feature of prostatic adenocarcinoma is its great variation in biologic ...
Prostate cancer represents a major global challenge, with 1.1 million new cases in 2012. According t...
We report our experience with 85 prostatic cancer patients aged 51-79 years, who underwent radical r...
SummaryBackgroundOptimum management of clinically localised prostate cancer presents unique challeng...
Background. DNA ploidy analysis has been investi-gated as a prognostic indicator in prostate cancer....
Prostate-specific antigen (PSA) and DNA ploidy as measured by flow cytometry were compared with conv...
BACKGROUND. The optimal approach to diagnosis and treatment of localized prostate cancer remains con...
Background: The ability to accurately predict tumor behavior and patient survival is a problem in ma...
CONTEXT: Given the highly variable behavior and clinical course of prostate cancer (PCa) and the mul...
ContextGiven the highly variable behavior and clinical course of prostate cancer (PCa) and the multi...
Background. DNA ploidy determination of carcino-mas in radical prostatectomy specimens has shown sig...
We have used image cell analysis to analyse nuclear DNA content on fine needle aspiration biopsies f...
Prostate cancer is one of the most frequent cancers in men and is a common cause of cancer-related d...
textabstractNo objective parameters have been found so far that can predict the biological...
Aneuploidy, defined as chromosome gains and losses, is a hallmark of cancer. However, compared with ...
Background. A characteristic feature of prostatic adenocarcinoma is its great variation in biologic ...
Prostate cancer represents a major global challenge, with 1.1 million new cases in 2012. According t...
We report our experience with 85 prostatic cancer patients aged 51-79 years, who underwent radical r...
SummaryBackgroundOptimum management of clinically localised prostate cancer presents unique challeng...